scispace - formally typeset
C

C. Mallikarjuna Rao

Researcher at Manipal University

Publications -  66
Citations -  1621

C. Mallikarjuna Rao is an academic researcher from Manipal University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 19, co-authored 54 publications receiving 1158 citations.

Papers
More filters
Journal ArticleDOI

Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.

TL;DR: This review deals with the recent developments in small molecule inhibitors as potential anti-cancer drugs targeting the epigenetic space and highlights the different types of epigenetic enzymes and protein domains with an emphasis on methylation and acetylation.
Journal ArticleDOI

Epigenetics in cancer: Fundamentals and Beyond

TL;DR: The information provided here elaborates the elementary phenomena of the various epigenetic regulators and discusses their alteration associated with the development of cancer.
Journal ArticleDOI

Synthesis and antitumor activity of optically active thiourea and their 2-aminobenzothiazole derivatives: a novel class of anticancer agents.

TL;DR: In preliminary MTT cytotoxicity studies the optically active thiourea derivatives (IVe, IVf and IVh) were found most effective and in alkaline comet assay the compounds (IVa-h and Va-h) showed dose-dependent DNA damaging activity.
Journal ArticleDOI

Effect of sesamol on radiation-induced cytotoxicity in Swiss albino mice.

TL;DR: Pretreatment with SM (50mg/kg bw) in mice irradiated with 15Gy significantly reduced dead, inflammatory, mitotic and goblet cells in irradiated jejunum, and increased crypt cells, maintained villus height, and prevented mucosal erosion.
Journal ArticleDOI

Silymarin liposomes improves oral bioavailability of silybin besides targeting hepatocytes, and immune cells.

TL;DR: The lecithin-based carrier system of silymarin is developed by incorporating phytosomal-liposomal approach to increase its oral bioavailability and to make it target-specific to the liver for enhanced hepatoprotection and better anti-inflammatory effects.